Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 1977-01-01 (49 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MONTMELIAN (73800), Savoie
PHARMACIE LA SAVOYARDE : revenue, balance sheet and financial ratios
PHARMACIE LA SAVOYARDE is a French company
founded 49 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MONTMELIAN (73800),
this company of category PME
shows in 2023 a revenue of 4.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE LA SAVOYARDE (SIREN 308984434)
Indicator
2025
2024
2023
2022
2021
2020
Revenue
N/C
N/C
4 104 665 €
N/C
N/C
3 414 808 €
Net income
249 086 €
252 240 €
315 896 €
527 316 €
207 367 €
353 582 €
EBITDA
N/C
N/C
462 679 €
N/C
N/C
367 459 €
Net margin
N/C
N/C
7.7%
N/C
N/C
10.4%
Revenue and income statement
In 2025, PHARMACIE LA SAVOYARDE generates positive net income of 249 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2025: 354 k€ -> 249 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
249 086 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 35%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 52%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
35.471%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
51.856%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE LA SAVOYARDE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
2024
2025
Debt ratio
1.979
1.793
0.511
33.965
40.16
35.471
Financial autonomy
60.246
43.576
63.98
55.698
48.306
51.856
Repayment capacity
0.008
None
None
0.746
None
None
Cash flow / Revenue
10.699%
None%
None%
8.904%
None%
None%
Sector positioning
Debt ratio
35.472025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good+8 pts over 3 years
In 2025, the debt ratio of PHARMACIE LA SAVOYARDE (35.47) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
51.86%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average-11 pts over 3 years
In 2025, the financial autonomy of PHARMACIE LA SAVOYARDE (51.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
0.75 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Excellent
In 2023, the repayment capacity of PHARMACIE LA SAVOYARDE (0.75) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 227.00. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
226.996
Liquidity indicators evolution PHARMACIE LA SAVOYARDE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2020
2021
2022
2023
2024
2025
Liquidity ratio
195.054
140.338
195.541
247.573
209.575
226.996
Interest coverage
0.101
None
None
0.543
None
None
Sector positioning
Liquidity ratio
227.02025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good
In 2025, the liquidity ratio of PHARMACIE LA SAVOYARDE (227.00) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
0.54x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of PHARMACIE LA SAVOYARDE (0.5x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE LA SAVOYARDE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
2024
2025
Operating WCR
585 127 €
0 €
0 €
484 597 €
0 €
0 €
Inventory turnover (days)
24
0
0
23
0
0
Customer payment term (days)
8
0
0
4
0
0
Supplier payment term (days)
37
0
0
31
0
0
Positioning of PHARMACIE LA SAVOYARDE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE LA SAVOYARDE is estimated at
3 956 760 €
(range 2 685 076€ - 6 208 702€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
2685k€3956k€6208k€
3 956 760 €Range: 2 685 076€ - 6 208 702€
NAF 5 année 2025
Valuation method used
Net Income Multiple
249 086 €
×
15.9x
=3 956 761 €
Range: 2 685 077€ - 6 208 702€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE LA SAVOYARDE with other companies in the same sector:
Frequently asked questions about PHARMACIE LA SAVOYARDE
What is the revenue of PHARMACIE LA SAVOYARDE ?
The revenue of PHARMACIE LA SAVOYARDE in 2023 is 4.1 M€.
Is PHARMACIE LA SAVOYARDE profitable?
Yes, PHARMACIE LA SAVOYARDE generated a net profit of 249 k€ in 2025.
Where is the headquarters of PHARMACIE LA SAVOYARDE ?
The headquarters of PHARMACIE LA SAVOYARDE is located in MONTMELIAN (73800), in the department Savoie.
Where to find the tax return of PHARMACIE LA SAVOYARDE ?
The tax return of PHARMACIE LA SAVOYARDE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE LA SAVOYARDE operate?
PHARMACIE LA SAVOYARDE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart